The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

Clinical trial NCT00630864 · COMPLETED

Trial details

NCT number: NCT00630864
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transthyretin-associated Amyloidosis With Polyneuropathy

Start date: 2008-06-01
Primary completion: 2010-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.